Limiting saturated fat intake can decrease a person’s risk of adverse cardiovascular events by a significant margin, according to a new systematic review of 15 different studies.
Treating atrial fibrillation (AF) patients with catheter ablation is associated with a decreased risk of mortality, heart failure admission and stroke, according to new findings published in the Journal of the American Heart Association.
As protests continue throughout the world in the wake of George Floyd’s death, the Society of Thoracic Surgeons has issued a statement condemning racism and violence.
Hospitals throughout the United States have reported that a general fear of COVID-19 has led to significant drops in patients presenting with heart attack symptoms and other cardiovascular issues.
The use of hydroxychloroquine and chloroquine as potential COVID-19 treatments has been one of the pandemic’s biggest stories, with some studies revealing promise and others offering reasons for concern.
Non-vitamin K antagonist oral anticoagulants are a valuable treatment option for atrial fibrillation patients with a prior intracranial hemorrhage, according to new findings published in JAMA Network Open.
The Association of Black Cardiologists, American Heart Association and American College of Cardiology have collaborated on a joint statement that touches on the death of George Floyd and its connection to the cardiovascular health of racial minorities in the United States.
The emergency use authorization covers patients who experience right-sided heart failure following left ventricular assist device implantation, myocardial infarction, heart transplant or open-heart surgery.
